MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
about
Development and Implementation of an End-Effector Upper Limb Rehabilitation Robot for Hemiplegic Patients with Line and Circle Tracking Training.BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.
P2860
MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@en
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@nl
type
label
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@en
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@nl
prefLabel
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@en
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@nl
P2093
P2860
P356
P1433
P1476
MLL-AF9 and MLL-AF4 oncofusion ...... 11q23 acute myeloid leukemia.
@en
P2093
A M Sotoca
B A van der Reijden
H G Stunnenberg
K H M Prange
T Kuznetsova
P2860
P2888
P304
P356
10.1038/ONC.2016.488
P407
P577
2017-01-23T00:00:00Z
P6179
1074203638